دورية أكاديمية

Combination therapy using Cel-CSO/Taxol NPs for reversing drug resistance in breast cancer through inhibiting PI3K/AKT/NF-κB/HIF-1α pathway

التفاصيل البيبلوغرافية
العنوان: Combination therapy using Cel-CSO/Taxol NPs for reversing drug resistance in breast cancer through inhibiting PI3K/AKT/NF-κB/HIF-1α pathway
المؤلفون: Zeng, HuahuiAff1, Aff4, Zeng, Xiaohu, Wang, CanAff1, Aff4, Wang, Guoqiang, Tian, Qikang, Zhao, Junwei, Zhao, Lingzhou, Li, Ruiqin, Luo, Ying, Peng, Haotian, Zhang, ZhenqiangAff1, IDs13346024016533_cor11, Li, XiaofangAff1, IDs13346024016533_cor12, Wu, XiangxiangAff1, IDs13346024016533_cor13
المصدر: Drug Delivery and Translational Research: An Official Journal of the Controlled Release Society. :1-19
قاعدة البيانات: Springer Nature Journals
الوصف
تدمد:2190393X
21903948
DOI:10.1007/s13346-024-01653-3